Adjuvant chemoradiotherapy with epirubicin, cisplatin, and fluorouracil compared with adjuvant chemoradiotherapy with fluorouracil and leucovorin after curative resection of gastric cancer: results from CALGB 80101 (Alliance). J Clin Oncol 2017; 35: 3671-3677.
Published: 17th May 2018
Authors: Fuchs CS, Niedzwiecki D, Mamon HJ, Tepper JE, Xing Y, Swanson RS et al.
Some 546 patients were included and followed for a median 6.5 years. The new regimen did not improve overall 5-year survival (44 per cent in both groups) or disease-free survival: 37 per cent, versus 39 per cent with standard chemotherapy.Pubmed Link
You may also be interested in
Effect of perioperative oral nutritional supplementation in malnourished patients who undergo gastrectomy: a prospective randomized trial. Surgery 2018; 164: 1263-1270.
Authors: Kong S-H, Lee H-J, Na J-R, Kim WG, Han D-S, Park S-H et al.
Helicobacter pylori therapy for the prevention of metachronous gastric cancer. N Engl J Med 2018; 378: 1085-1095.
Authors: Choi IJ, Kook M-C, Kim Y-I, Cho S-J, Lee JY, Kim CG et al.
Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the adjuvant chemoradiotherapy in stomach tumors trial, including survival and subset analyses. J Clin Oncol 2015; 33: 3130-3136.
Authors: Park SH, Sohn TS, Lee J, Lim DH, Hong ME, Kim K-M et al. et al.
Effect of daikenchuto, a traditional Japanese herbal medicine, after total gastrectomy for gastric cancer: a multicenter, randomized, double-blind, placebo-controlled, phase II trial. J Am Coll Surg 2015; 221: 571–578.
Authors: Yoshkawa K, Shimada M, Wakabayashi G, Ishida K, Kaiho T, Kitagawa Y et al. et al.
Preoperative vs postoperative eradication of Helicobacter pylori in 150 patients with gastric cancer: a randomized controlled trial. J Am Coll Surg 2015; 221: 273–279.
Authors: Honda M, Hiki N, Nunobe S, Ohashi M, Kumagai K, Hashimoto Y et al. et al.
Clinical effectiveness of neoadjuvant chemotherapy in advanced gastric cancer: an updated meta-analysis of randomized controlled trials. Eur J Surg Oncol 2014; 40: 1321-1330.
Authors: Xiong B, Ma L, Cheng Y, Zhang C
Intensive versus conventional insulin therapy in type 2 diabetes patients undergoing D2 gastrectomy for gastric cancer: a randomised controlled trial. World J Surg 2011; 35: 85-92.
Authors: Cao S-G, Ren J-A, Shen B, Chen D, Zhou Y-B, Li J-S. et al.
Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment for Cancer randomized trial 40954. J Clin Oncol 2010; 29: 5210–5218.
Authors: Schuhmacher C, Gretschel S, Lordick F, Reichardt P, Hohenberger W, Elsenberger CF et al. et al.
Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial Lancet 2008; 372: 392¿397
Authors: Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S et al et al.
Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. J Natl Cancer Inst 2008; 100: 388-398.
Authors: Di Costanzo F, Gasperoni S, Manzione L, Bisagni G, Labianca R, Bravi S et al.
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007; 357: 1810-1820.
Authors: Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A et al.
Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial. J Natl Cancer Inst 2007; 99: 601-607.
Authors: Cascinu S, Labianca R, Barone C, Santoro A, Carnaghi C, Cassano A et al.